August 2024
Know What’s New with RSV Vaccines for Older Adults
New CDC guidance is more clear-cut than last year’s. Clinicians need to know what’s changed. Our Letter articles provide guidance about which patients should receive the RSV vaccine, and clarify when it is not recommended and why. We also give advice about product selection, dosing, and when administration is preferred. Readers can find product comparisons in our chart, Preventing RSV, along with more guidance, including recommendations for pregnant patients.
Read More:
Community Topic: Be Prepared for Conversations About “Doxy PEP”
New CDC guidance recommends prescribing doxycycline for certain high-risk patients to take after sex to prevent bacterial sexually transmitted infections (STIs). Clinicians need to know about this new practice. Our Letter articles clarify which patients are likely to benefit from doxy PEP and how effective it is in preventing bacterial STIs. We provide guidance on how to dose doxy PEP and which product to use. Our articles also give guidance on points for patient education about doxy PEP and overall sexual health. Our resources, HIV Pre-Exposure Prophylaxis (PrEP) and HIV Postexposure Prophylaxis (PEP) Checklist, can support these conversations.
Read More:
Hospital Pharmacy: Use a Practical Approach to Manage Opioid-Allergy Alerts
Less than 2% of reactions to opioids are a true allergy, but most reactions are documented incorrectly or incompletely. Our article provides a practical approach to handling opioid-allergy alerts. We discuss common adverse effects that should be labeled as “intolerances” and clarify symptoms of “pseudoallergy.” We also discuss true opioid allergies and how to manage opioids in these patients. Our resource, Opioid Allergy, provides guidance on cross-reactivity when patients have a true, severe allergy, along with an algorithm to guide treatment options.
Read More:
A new study linking low-calorie sweetener xylitol to heart attack and stroke is getting a lot of attention and generating concerns about safety. Our NatMed article explains that this new research only suggests a potential link. Even so, it’s putting a spotlight on sugar substitutes in general. For now, we advise caution and recommend only using xylitol in small amounts and avoiding processed foods loaded with sugar alternatives.
A new study linking low-calorie sweetener xylitol to heart attack and stroke is getting a lot of attention and generating concerns about safety. Our NatMed article explains that this new research only suggests a potential link. Even so, it’s putting a spotlight on sugar substitutes in general. For now, we advise caution and recommend only using xylitol in small amounts and avoiding processed foods loaded with sugar alternatives.
We have a packed tradeshow schedule this year and would love to meet with you in person! Send us a meeting request if you’ll be attending any of these shows!
Check out where we’ll be in the coming months:
Have you ever wondered who faces a greater risk of hazardous drug (HD) exposure—pharmacy personnel or certifiers? The answer depends on various factors, but one thing is clear, both groups can face significant risks. In the latest blog post, Adam West explores the hidden dangers that certifiers may encounter, and often without the proper training or awareness of HD exposure. It raises critical questions about our responsibilities in ensuring the safety of everyone working in and around HD environments.
Have you ever wondered who faces a greater risk of hazardous drug (HD) exposure—pharmacy personnel or certifiers? The answer depends on various factors, but one thing is clear, both groups can face significant risks. In the latest blog post, Adam West explores the hidden dangers that certifiers may encounter, and often without the proper training or awareness of HD exposure. It raises critical questions about our responsibilities in ensuring the safety of everyone working in and around HD environments.
We know that keeping up with policy changes can be challenging, so we’ve created a concise summary of the 2024 legislative session, providing you with a quick and easy way to learn about important pharmacy-related legislative activities you may have missed. Download the summary here.
Here Are the Key Highlights:
HIV PrEP/Post-Exposure Prescribing and Dispensing
States such as California, Delaware, Florida, Louisiana, New Jersey, and Tennessee have introduced or updated legislation to allow pharmacists to prescribe and dispense HIV medications.
Test and Treat for Flu, COVID-19, and Others
Legislation in Tennessee, Oregon, Maryland, and Michigan has expanded the role of pharmacists to include testing and treating for conditions like the flu, COVID-19, and other illnesses.
EpiPen Prescribing and Dispensing
Alaska, Tennessee, and New Hampshire have introduced legislative updates allowing pharmacists to prescribe and dispense EpiPens. The new regulations may include expanded training for pharmacists or protocols to streamline the prescribing process.
Opioid, Substance Use Disorder, and Controlled Substances Legislative Updates
The opioid crisis continues to be a major focus of legislative efforts. Notable updates include:
To learn more about how Bula can help keep your organization compliant, contact us today.
In the wake of recent opioid settlements, it's more vital than ever to ensure that your pharmacy team is practicing safely and remaining compliant with controlled substances and diversion guidelines.
Our Controlled Substances & Diversion Training program is the gold standard in pharmacy training developed specifically for pharmacists and pharmacy technicians. It is the perfect complement to existing in-house trainings and ensures your staff are getting trained with the most updated information that addresses the day-to-day issues that arise and how to solve for them.
What You'll Love Most About This Program:
In this webinar, compounding experts, Latousha Jackson, BS, PharmD, BCSCP and Adam West, NSF/ANSI 49, RCP-SCF discuss emergency preparedness and pharmacy compliance. Adam uses past instances to address the direct impact pharmacies face during emergency situations. He explains the importance of having an effective training program in place to ensure your pharmacy team is prepared and offers expert tips on strategies for how to maintain smooth operations and compliance. Latousha leads the Q&A session, drawing on her expertise to address critical questions.
Check out this month’s podcast, Specialty Meds: Navigating Barriers, and listen in as our expert panel discusses the challenges and solutions for ensuring access to specialty medications, including how social determinants of health play a role and strategies to overcome barriers caused by these factors.
Pharmacist’s Letter and Prescriber Insights subscribers can get CE credit for listening to our podcasts.